Phytocannabinoids and synthetic cannabinoids – pharmacotherapeutic aspects
-
Published:2023
Issue:210
Volume:1
Page:10
-
ISSN:1584-6539
-
Container-title:Farmacist.ro
-
language:en
-
Short-container-title:Farmacist.ro
Author:
Blebea Nicoleta Mirela
Reference11 articles.
1. Reekie TA, Scott MP, Kassiou M. The evolving science of phytocannabinoids. Nat Rev Chem. 2017 Dec; vol. 2. https://doi.org/10.1038/s41570-017-0101.
2. Nelson KM, Bisson J, Singh G, Graham JG, Chen SN, Friesen JB, Dahlin JL, Niemitz M, Walters MA, Pauli GF. The Essential Medicinal Chemistry of Cannabidiol (CBD). J Med Chem. 2020 Nov 12;63(21):12137-12155.
3. Fasinu PS, Phillips S, ElSohly MA, Walker LA. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents. Pharmacotherapy. 2016 Jul;36(7):781-96. doi: 10.1002/phar.1780.
4. Blebea NM, Rambu D, Costache T, Negreş S. Very Fast RP–UHPLC–PDA Method for Identification and Quantification of the Cannabinoids from Hemp Oil. Applied Sciences. 2021;11(20):9414. https://doi.org/10.3390/app11209414.
5. Abu-Sawwa R, Scutt B, Park Y. Emerging Use of Epidiolex (Cannabidiol) in Epilepsy. J Pediatr Pharmacol Ther. 2020;25(6):485-499. doi: 10.5863/1551-6776-25.6.485.